Early discharge after high dose chemotherapy is safe and feasible: a prospective evaluation of 6 years of home care

References

• Meyers JD. Infection in bone marrow transplant recipients. Am J Med 1986;81:27–38.
   PubMed Web of Science ®Google Scholar
• Bodey GP. The treatment of febrile neutropenia: from the dark ages to the present. Support Care Cancer 1997;5:351–357.
   PubMed Web of Science ®Google Scholar
• Tiel van FH, Harbers MM, Kessels AG, et al. Home care versus hospital care of patients with haematological malignancies and chemotherapy-induced cytopenia. Ann Oncol 2005;16:195–205.
   PubMed Web of Science ®Google Scholar
• Moores KG. Safe and effective outpatient treatment of adults with chemotherapy-induced neutropenic fever. Am J Health Syst Pharm 2007;64:717–722.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Klar N, Weeks JC, et al. Predicting costs of stem-cell transplantation. J Clin Oncol 2000;18:64–71.
   PubMed Web of Science ®Google Scholar
• Uyl-de Groot CA, Gelderblom-den Hartog J, Huijgens PC, et al. Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands. J Hematother Stem Cell Res 2001;10:187–192.
   PubMedGoogle Scholar
• Rizzo JD, Vogelsang GB, Krumm S, et al. Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? J Clin Oncol 1999;17:2811–2818.
   PubMed Web of Science ®Google Scholar
• de Lalla F. Outpatient therapy for febrile neutropenia: clinical and economic implications. Pharmacoeconomics 2003;21:397–413.
   PubMed Web of Science ®Google Scholar
• Jones JA, Qazilbash MH, Shih YC, et al. In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer 2008;112:1096–1105.
   PubMed Web of Science ®Google Scholar
• Girmenia C, Alimena G, Latagliata R, et al. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit. Haematologica 1999;84:814–819.
   PubMed Web of Science ®Google Scholar
• Herrmann RP, Trent M, Cooney J, et al. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 1999;24:1213–1217.
   PubMed Web of Science ®Google Scholar
• Svahn BM, Remberger M, Myrbäck KE, et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002;100:4317–4324.
   PubMed Web of Science ®Google Scholar
• Fernández-Avilés F, Carreras E, Urbano-Ispizua A. Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. J Clin Oncol 2006;24:4855–4861.
   PubMed Web of Science ®Google Scholar
• Møller T, Nielsen OJ, Welinder P, et al. Safe and feasible out patient treatment following induction and consolidation chemotherapy for patients with acute leukaemia. Eur J Haematol 2010;84:316–322
   PubMed Web of Science ®Google Scholar
• Jagannath S, Vesole DH, Zhang M, et al. Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma. Bone Marrow Transplant 1997;20:445–450.
   PubMed Web of Science ®Google Scholar
• Morabito F, Martino M, Stelitano C, et al. Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma. Haematologica 2002;87: 1192–1199.
   PubMed Web of Science ®Google Scholar
• Naithani R, Kumar R, Mahapatra M, et al. Early discharge from hospital after consolidation chemotherapy in acute myeloid leukemia in remission: febrile neutropenic episodes and their outcome in a resource poor setting. Haematologica 2008;93:1416–1418.
   PubMed Web of Science ®Google Scholar
• Sive J, Ardeshna KM, Cheesman S, et al. Hotel-based ambulatory care for complex cancer patients: a review of the University Hospital experience. Leuk Lymphoma 2012;53:2397–2404.
   PubMed Web of Science ®Google Scholar
• Summers N, Dawe U, Stewart DA. A comparison of inpatient and outpatient ASCT. Bone Marrow Transplant 2000;26:389–395.
   PubMed Web of Science ®Google Scholar
• Mank A, Van der Lelie J, de Vos R, et al. Safe early discharge for patients undergoing high dose chemotherapy with or without stem cell transplantation: a prospective analysis of clinical variables predictive for complications after treatment. J Clin Nurs 2011;20: 388–395.
   PubMed Web of Science ®Google Scholar
• van Campen C, Sixma H, Friele RD, et al. Quality of care and patient satisfaction:a review of measuring instruments. Med Care Res Rev 1995;52:109–133.
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Muus P, Schattenberg A, et al. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 1992;9:409–413.
   PubMed Web of Science ®Google Scholar
• Dykewicz C; Centers for Disease Control and Prevention (U.S.); Infectious Diseases Society of America; American Society of Blood and Marrow Transplantation. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. Clin Infect Dis 2001;33:139–144.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730–751.
   PubMed Web of Science ®Google Scholar
• de Pauw B, Walsh TJ, Donnelly JP, et al.; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813–1821.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events v.3.0 (CTCAE). Available from: https://ced4xbn2cbj5hh2iop.sec.amc.nl/protocolDevelopment/electronic_applications/ctc.htm
   Google Scholar
• McQuellon RP, Russell GB, Cella DF, et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997;19:357–368.
   PubMed Web of Science ®Google Scholar